Viral hepatitis: yesterday, today, tomorrow

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

In this year, the Central Research Institute of Epidemiology is 60 years old. The paper presents the scientific activity of the Clinical Department and its divisions from the late 1970s to the present day. The main scientific works conducted under the guidance of scientists, such as Professors A.V. Zmyzgov and A.R. Reizis, are highlighted. At this time, they began to actively studied the cellular and humoral components of immunity, the hemostatis system, the state of the antioxidant system and lipid peroxidation, to test new therapies, such as hyperbaric oxygenation, plasmapheresis, laser therapy, interferons, etc. in patients with viral hepatitis.

Full Text

Restricted Access

About the authors

Vera V. Makashova

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Author for correspondence.
Email: veramakashova@yandex.ru
ORCID iD: 0000-0002-0982-3527

MD, Professor, Leading Researcher

Russian Federation, Moscow

Tatyana S. Nikitina

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: nikitina-ts@mail.ru
ORCID iD: 0009-0004-5627-2424

Cand. Med. Sci., Academic Secretary

Russian Federation, Moscow

Zhanna B. Ponezheva

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: doktorim@mail.ru
ORCID iD: 0000-0002-6539-4878

MD, Head, Clinical Department of Infectious Pathology

Russian Federation, Moscow

References

  1. Blumberg B.S., Alter H.J., Visnich S.A. A new antigen in leukemia sera. JAMA 1965; 191: 541.
  2. Dane D.S., Cameron K.H., Brig M. Virus-like particles in the blood serum of patients with Australian antigen-associated hepatitis. Lancet 1970; 1(7649): 695–8. doi: 10.1016/s0140-6736(70)90926-8. PMID: 4190997
  3. Rizzetto M., Canese M.G., Aricò S., Crivelli O., Trepo C., Bonino F. et al. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 1977;18(2): 997–1003. — doi: 10.1136/gut.18.12.997. PMID: 75123
  4. Press release: The Nobel Prize in Physiology or Medicine 2020. https://www.nobelprize.org/prizes/medicine/2020/press-release/
  5. http://86.rospotrebnadzor.ru/news/28-iyulya-vsemirnyj-den-borby-s-gepatitom-28-07-2022
  6. http://www.cardio.by/ponimanie-virusnogo-gepatita-kak-globalnoy-problemi-zdravoohraneniya
  7. https://www.who.int/ru/campaigns/world-hepatitis-day/2022
  8. https://imunofan.ru/intervyu-professora-cznii-epidemiologii-minzdrava-rossii-v-v-lebedeva/
  9. Понежева Ж.Б., Макашова В.В., Маннанова И.В. Хронический гепатит С: современные аспекты эпидемиологии, иммунопатогенеза и терапии. /Под ред. В.Г. Акимкина. М.: Медконгресс, 2021. 84 с. Ponezheva Zh.B., Makashova V.V., Mаnnanova I.V. [Chronic hepatitis C: modern aspects of epidemiology, immunopathogenesis and therapy]. /V.G. Аkimkin, еd. Moscow: Medical Congress, 2021. 84 p.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2023 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies